Articles citing this paper
Generic drug prices and policy in Australia: room for improvement? A comparative analysis with England
Sarah J. Mansfield A
+ Author Affiliations
- Author Affiliations
A Department of General Practice, Deakin University, 2–18 Colac Road, Belmont, Vic. 3216, Australia. Email: s.mansfield1@gmail.com
Australian Health Review 38(1) 6-15 https://doi.org/10.1071/AH12009
Submitted: 30 November 2012 Accepted: 11 November 2013 Published: 31 January 2014
12 articles found in Crossref database.
Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure
Lee Leonard, Kim Hansoo
Value in Health Regional Issues. 2024 40 p.27
The big cost of big medicine – calculating the rent in private healthcare
Stelzner Mark Joseph, Nam Daniel Taekmin
Review of Social Economy. 2022 80(4). p.491
Knowledge, perceptions and practices of pharmacists regarding generic substitution in China: a cross-sectional study
Qu Jinghan,
Zuo Wei,
Wang Shaohong,
Du Liping,
Liu Xin,
Gao Yang,
Li Jiantao,
Pan Hui,
Du Xiaoli,
Mei Dan,
Took Roxane L,
Schafermeyer Kenneth W,
Lukas Stephanie, Zhang Bo
BMJ Open. 2021 11(10). p.e051277
Challenges for Medicare and universal health care in Australia since 2000
Angeles Mary Rose,
Crosland Paul, Hensher Martin
Medical Journal of Australia. 2023 218(7). p.322
Medicine Price Surveys, Analyses and Comparisons (2019)
Análise dos preços regulados e praticados para os medicamentos mais consumidos no Brasil*
Pontes Marcela,
Leite Silvana Nair, Ribeiro Alane Andrelino
Economia e Sociedade. 2024 33(1). p.201
New Zealand patients’ understanding of brand substitution and opinions on copayment options for choice of medicine brand
Lessing Charon,
Ashton Toni, Davis Peter
Australian Health Review. 2016 40(3). p.345
A comparison of generic drug prices in seven European countries: a methodological analysis
Wouters Olivier J., Kanavos Panos G.
BMC Health Services Research. 2017 17(1).
Price and utilisation differences for statins between four countries
Thai Loc Phuoc,
Vitry Agnes Isabelle, Moss John Robert
Expert Review of Pharmacoeconomics & Outcomes Research. 2018 18(1). p.71
A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data
Ofori-Asenso Richard,
Ilomäki Jenni,
Zomer Ella,
Curtis Andrea J.,
Zoungas Sophia, Liew Danny
Cardiovascular Drugs and Therapy. 2018 32(3). p.265
Pathways to ensure universal and affordable access to hepatitis C treatment
Douglass Caitlin H.,
Pedrana Alisa,
Lazarus Jeffrey V.,
‘t Hoen Ellen F. M.,
Hammad Radi,
Leite Ricardo Baptista,
Hill Andrew, Hellard Margaret
BMC Medicine. 2018 16(1).
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Godman Brian,
Malmström Rickard E,
Diogene Eduardo,
Gray Andy,
Jayathissa Sisira,
Timoney Angela,
Acurcio Francisco,
Alkan Ali,
Brzezinska Anna,
Bucsics Anna,
Campbell Stephen M,
Czeczot Jadwiga,
de Bruyn Winnie,
Eriksson Irene,
Yusof Faridah Aryani Md,
Finlayson Alexander E,
Fürst Jurij,
Garuoliene Kristina,
Guerra Júnior Augusto,
Gulbinovič Jolanta,
Jan Saira,
Joppi Roberta,
Kalaba Marija,
Magnisson Einar,
McCullagh Laura,
Miikkulainen Kaisa,
Ofierska-Sujkowska Gabriela,
Pedersen Hanne Bak,
Selke Gisbert,
Sermet Catherine,
Spillane Susan,
Supian Azuwana,
Truter Ilse,
Vlahović-Palčevski Vera,
Vien Low Ee,
Vural Elif H,
Wale Janet,
Władysiuk Magdałene,
Zeng Wenjie, Gustafsson Lars L
Expert Review of Clinical Pharmacology. 2015 8(1). p.77
